Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Immunity|July 4, 2012
No ubiquitin anchors and fully RIGgedLynn Verstrepen, Rudi Beyaert
Biochemical Pharmacology|December 3, 2014
Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammationLynn Verstrepen, Rudi Beyaert
Biochemical Pharmacology|March 20, 2016
TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell deathAlice Borghi, Lynn Verstrepen, Rudi Beyaert
Advances in Experimental Medicine and Biology|October 11, 2014
The biology of A20-binding inhibitors of NF-kappaB activation (ABINs)Lynn Verstrepen, Isabelle Carpentier, Rudi Beyaert
Trends in Biochemical Sciences|May 7, 2011
TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyondLynn Verstrepen, Kelly Verhelst, Isabelle Carpentier, et al.
Biochemical Pharmacology|January 22, 2013
IκB kinase ε (IKKε): a therapeutic target in inflammation and cancerKelly Verhelst, Lynn Verstrepen, Isabelle Carpentier, et al.
Biochemical Pharmacology|May 26, 2009
ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signalingLynn Verstrepen, Isabelle Carpentier, Kelly Verhelst, et al.
Biochemical Pharmacology|July 27, 2011
Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do notKelly Verhelst, Lynn Verstrepen, Isabelle Carpentier, et al.
Frontiers in Nutrition|December 31, 2025
Tributyrin (CoreBiome®) enhances butyrate levels and modulates the gut microbiota, barrier function, and immune response in vitroCindy Duysburgh, Lynn Verstrepen, Lieven Van Meulebroek, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Pageof 4